chr11-86245240-G-A
Variant summary
Our verdict is Likely benign. Variant got -6 ACMG points: 0P and 6B. BP4_ModerateBS2
The ENST00000263360.11(EED):c.11G>A(p.Arg4Lys) variant causes a missense change. The variant allele was found at a frequency of 0.00000434 in 1,613,290 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 12/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. R4M) has been classified as Uncertain significance.
Frequency
Consequence
ENST00000263360.11 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -6 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
EED | NM_003797.5 | c.11G>A | p.Arg4Lys | missense_variant | 1/12 | ENST00000263360.11 | NP_003788.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
EED | ENST00000263360.11 | c.11G>A | p.Arg4Lys | missense_variant | 1/12 | 1 | NM_003797.5 | ENSP00000263360 | P1 |
Frequencies
GnomAD3 genomes AF: 0.0000132 AC: 2AN: 152036Hom.: 0 Cov.: 30
GnomAD3 exomes AF: 0.00000405 AC: 1AN: 247112Hom.: 0 AF XY: 0.00000745 AC XY: 1AN XY: 134160
GnomAD4 exome AF: 0.00000342 AC: 5AN: 1461254Hom.: 0 Cov.: 31 AF XY: 0.00000550 AC XY: 4AN XY: 726912
GnomAD4 genome AF: 0.0000132 AC: 2AN: 152036Hom.: 0 Cov.: 30 AF XY: 0.0000269 AC XY: 2AN XY: 74256
ClinVar
Submissions by phenotype
Cohen-Gibson syndrome Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Mar 23, 2020 | In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. Algorithms developed to predict the effect of missense changes on protein structure and function (SIFT, PolyPhen-2, Align-GVGD) all suggest that this variant is likely to be tolerated, but these predictions have not been confirmed by published functional studies and their clinical significance is uncertain. This variant has not been reported in the literature in individuals with EED-related conditions. This variant is not present in population databases (ExAC no frequency). This sequence change replaces arginine with lysine at codon 4 of the EED protein (p.Arg4Lys). The arginine residue is weakly conserved and there is a small physicochemical difference between arginine and lysine. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at